Search for: "HOLDER v. WYETH" Results 21 - 40 of 70
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Aug 2012, 10:09 pm by FDABlog HPM
  Wyeth would both forgo marketing its own authorized generic during that period and allow Wyeth’s generic Effexor to come to market early” (emphasis in original). [read post]
28 Jul 2014, 5:38 am
’`Wydase is a medical preparation of highly purified bovine testicular enzyme, made previously by Wyeth Pharmaceuticals in England. [read post]
22 Aug 2014, 9:22 am
A short history of recent implied preemption “impossibility” decisions:  (1) In Wyeth v. [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb)   General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb)   General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
8 Mar 2012, 10:08 am by Bexis
Wyeth, Inc., 588 F.3d 603, 612-14 (8th Cir. 2009), reaffirmed after remand, 658 F.3d 867 (8th Cir. 2011).Also there’s Smith v. [read post]
30 Jul 2013, 2:01 pm by Bexis
Lexis 1688, at *25-26 n.8 (citing Wyeth v. [read post]
22 Jun 2010, 7:45 am by Jay Willis
Holder dominates the headlines. [read post]
23 Apr 2014, 7:30 am by Joe Consumer
  Interestingly, Much of the argument concerned a 2009 ruling, Wyeth v. [read post]
31 Oct 2013, 5:00 am
  The facts sound rather like Wyeth v. [read post]
27 Oct 2011, 2:42 pm by FDABlog HPM
  But it fits hand-in-glove with the Plaintiffs’ endgame: that “a court should apply the impossibility preemption analysis utilized in [Wyeth v. [read post]
17 May 2021, 12:45 am by Annsley Merelle Ward
  MSD / Wyeth, District Court of The Hague 11 November 2020 (Judges Kokke, Aalbers and Schüller) [Dutch decision here]In a second decision on auxiliary requests in a case between pharmaceutical companies MSD and Wyeth, the District Court – in a panel with two of the same judges as in the Biogen/Richter case – decided along the same lines as the Biogen/Richter case with regard to the scope of the validity debate after (unconditional) auxiliary requests.Wyeth is… [read post]